HLN
Haleon plc (HLN)
Healthcare • NYSE • $9.11-2.04%
- Symbol
- HLN
- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Price
- $9.11
- Daily Change
- -2.04%
- Market Cap
- $40.43B
- Trailing P/E
- 18.22
- Forward P/E
- 14.93
- 52W High
- $11.42
- 52W Low
- $8.71
- Analyst Target
- $11.74
- Dividend Yield
- +2.09%
- Beta
- 0.25
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Theraflu, and Flonase brands for respiratory issues; and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brand…
Company websiteResearch HLN on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.